Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

ClinicalTrials.gov ID: NCT05971940

Public ClinicalTrials.gov record NCT05971940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 3:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes and inadequate glycemic control with diet and exercise alone. The study will last approximately 54 weeks.

Study identification

NCT ID
NCT05971940
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
559 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 9, 2023 (Actual)
Primary completion
Apr 3, 2025 (Actual)
Completion
Apr 3, 2025 (Actual)
Last update posted
Sep 3, 2026

2023 – 2025

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Syed Research Consultants Llc Sheffield Alabama 35660 —
Epic Medical Research - Surprise Surprise Arizona 85378 —
Quality of Life Medical & Research Center Tucson Arizona 85712 —
Neighborhood Healthcare Institute of Health Escondido California 92025 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255 —
Ark Clinical Research Long Beach California 90815 —
Velocity Clinical Research, Westlake Los Angeles California 90057 —
Infinity Clinical Research - Norco Norco California 92860 —
Norcal Endocrinology & Internal Medicine San Ramon California 94583 —
University Clinical Investigators, Inc. Tustin California 92780 —
Connecticut Clinical Research - Cromwell Cromwell Connecticut 06416 —
Invictus Clinical Research Group Coconut Creek Florida 33073 —
Hillcrest Medical Research DeLand Florida 32720 —
K2 Medical Research Maitland Florida 32751 —
Global Health Research Center, Inc. Miami Lakes Florida 33016 —
West Orange Endocrinology Ocoee Florida 34761 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291 —
Family First Medical Center Idaho Falls Idaho 83404 —
American Health Network of Indiana, LLC - Muncie Muncie Indiana 47304 —
Tekton Research - Wichita Wichita Kansas 67218 —
Alliance for Multispecialty Research, LLC New Orleans Louisiana 70119 —
Revival Research Institute Dearborn Michigan 48126 —
Billings Clinic Billings Montana 59101 —
Ellipsis Research Group - Brooklyn - 7th Street Brooklyn New York 11215 —
Central New York Clinical Research Manlius New York 13104 —
Monroe Biomedical Research Monroe North Carolina 28112 —
Lucas Research - New Bern New Bern North Carolina 28562 —
Centricity Research Dublin Multispecialty Dublin Ohio 43016 —
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069 —
The Corvallis Clinic, P.C. Corvallis Oregon 97330 —
Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair Pittsburgh Pennsylvania 15243 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
The Research Center of The Upstate Greenville South Carolina 29607 —
MDFirst Research, LLC Lancaster South Carolina 29720 —
The Jackson Clinic Jackson Tennessee 38305 —
Velocity Clinical Research, Dallas Dallas Texas 75230 —
Juno Research Houston Texas 77040 —
Endocrine Ips, Pllc Houston Texas 77079 —
Amir A Hassan, MD, PA Houston Texas 77089 —
Burke Internal Medicine and Research Burke Virginia 22015 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05971940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05971940 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →